Disc Medicine (IRON) Operating Expenses (2020 - 2026)
Disc Medicine (IRON) posted quarterly Operating Expenses of $65.1 million for Q2 2026, up 5.97% year-over-year from $61.4 million in Q2 2025, and down 6.4% quarter-over-quarter from $69.5 million in Q1 2026.
Disc Medicine (IRON) Operating Expenses (2020 - 2026) Analysis & Trends
Disc Medicine (IRON) has reported Operating Expenses for 7 consecutive years, with $65.1 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Operating Expenses rose 5.97% year-over-year to $65.1 million; the TTM figure through Jun 2026 stood at $269.3 million (up 59.55% YoY), while the FY2025 annual figure was $236.0 million, up 81.95% from the prior year.
- Operating Expenses retreated to $65.1 million in Q2 2026 per IRON's latest filing, from $69.5 million in the prior quarter.
- Across five years, Operating Expenses topped out at $69.5 million in Q1 2026 and bottomed at $10.0 million in Q1 2022.
- Historically, Operating Expenses has averaged $35.5 million across 5 years, with a median of $31.2 million in 2024.
- On a YoY basis, Operating Expenses climbed as much as 173.9% in 2022 and fell as far as 43.2% in 2022.
- Disc Medicine's Operating Expenses stood at $15.0 million in 2022, then surged by 97.82% to $29.7 million in 2023, then increased by 16.28% to $34.6 million in 2024, then jumped by 93.84% to $67.0 million in 2025, then slipped by 2.83% to $65.1 million in 2026.
- Business Quant data shows IRON's Operating Expenses at $65.1 million in Q2 2026, $69.5 million in Q1 2026, and $67.0 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Disc Medicine | 3.02 Bn | 3.02 Bn | - | 65.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 65.08 Mn |
| Mar 31, 2026 | 69.52 Mn |
| Dec 31, 2025 | 66.97 Mn |
| Sep 30, 2025 | 67.70 Mn |
| Jun 30, 2025 | 61.41 Mn |
| Mar 31, 2025 | 39.95 Mn |
| Dec 31, 2024 | 34.55 Mn |
| Sep 30, 2024 | 32.86 Mn |
| Jun 30, 2024 | 30.85 Mn |
| Mar 31, 2024 | 31.46 Mn |
| Dec 31, 2023 | 29.71 Mn |
| Sep 30, 2023 | 18.96 Mn |
| Jun 30, 2023 | 17.33 Mn |
| Mar 31, 2023 | 25.13 Mn |
| Dec 31, 2022 | 15.02 Mn |
| Sep 30, 2022 | 10.48 Mn |
| Jun 30, 2022 | 12.02 Mn |
| Mar 31, 2022 | 9.96 Mn |
| Dec 31, 2021 | -20.33 Mn |
| Sep 30, 2021 | 18.45 Mn |